Translational Medicine
UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria
By Juzer Kakal | May 1, 2020
Researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart.
UBC-led study finds trial drug can significantly block early stages of COVID-19 in engineered human tissues
By dcc2012 | April 2, 2020
The findings hold promise as a treatment capable of stopping early infection of the novel coronavirus.
Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19
By Bethany Becker | February 25, 2020
APN01, a drug made by Apeiron Biologics and developed based on the work of UBC’s Josef Penninger, is already shown to block viral spread in SARS.
New device identifies high-quality blood donors
By Reyhana Heatherington | February 5, 2020
Researchers tested stored red blood cells from eight different donors using a custom-made microfluidics device.